This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB01860/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB01860/identifier/pubchem-compound/
n4http://bio2rdf.org/drugbank:
n15http://linked.opendata.cz/resource/drugbank/drug/DB01860/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB01860/identifier/drugbank/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB01860/identifier/chemspider/
n8http://linked.opendata.cz/resource/drugbank/drug/DB01860/identifier/chebi/

Statements

Subject Item
n2:DB01860
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB01860 n14:DB01860
dcterms:title
Cordycepin Triphosphate
adms:identifier
n8:52316 n9:3AT n10:46936242 n11:1543 n12:DB01860 n15:46506331
n5:IUPAC-Name
n6:271B4DCB-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4DD1-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4DD0-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4DCD-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4DCE-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4DCF-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4DC9-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4DCA-363D-11E5-9242-09173F13E4C5 n6:271B4DC7-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4DC8-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4DD7-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4DD8-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4DD2-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4DD3-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4DD5-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4DD4-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4DD6-363D-11E5-9242-09173F13E4C5
n5:casRegistryNumber
73-04-1
n5:Bioavailability
n6:271B4DDD-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4DDF-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4DE0-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4DDC-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4DDB-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4DDE-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4DCC-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4DD9-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4DDA-363D-11E5-9242-09173F13E4C5